**Background**
Chronic inflammation and oxidative stress are central drivers in the pathogenesis of various metabolic and infectious diseases. In particular, secondary diabetic complications often arise from prolonged hyperglycemia, leading to tissue damage and systemic dysfunction. Furthermore, the inflammatory response, often characterized by the overproduction of nitric oxide (NO) and pro-inflammatory mediators, plays a critical role in the progression of infectious diseases, including HIV and COVID-19. Managing these pathways is essential for reducing tissue injury and improving clinical outcomes. In this context, we will introduce a potent antioxidative and anti-inflammatory agent – Benfotiamine.
**Definition**
Benfotiamine (S-Benzoylthiamine O-monophosphate) is a lipid-soluble derivative of vitamin B1 that exhibits potent antioxidative and anti-inflammatory activity. According to the Benfotiamine description, it is utilized extensively in the research of diabetic complications and infectious diseases.
**In Vitro and In Vivo Studies**
The Benfotiamine biological activity has been demonstrated across various experimental models. In vitro studies using BV-2 microglial cells showed that Benfotiamine (50-250 μM; pretreated for 30 min and then exposed to LPS for 24 h) decreases LPS-induced production of NO by suppressing iNOS-mRNA and protein levels. Additionally, when pretreated for 30 min and exposed to LPS for 6 h, Benfotiamine (50-250 μM) suppresses the mRNA expression of PTGS and the protein expression of COX-2 in BV2 cells. These results highlight its potential to attenuate inflammatory responses in microglia.
Regarding Benfotiamine In Vivo application, research indicates that Benfotiamine (100 mg/kg; i.p. for 14 d) effectively alleviates cerebral oxidative damage in FVB mice induced by streptozotocin (STZ). This protective effect occurs independently of advanced glycation end-products, tissue factor, and TNF-alpha. For researchers requiring specific Benfotiamine technical information, such as the Benfotiamine Formula (C19H23N4O6PS) or molecular weight (466.45), these parameters are critical for calculating precise experimental dosages. In conclusion, Benfotiamine is a versatile vitamin B1 derivative that serves as a powerful tool for studying the mitigation of oxidative damage and inflammation.
Keywords
Benfotiamine, 22457-89-2, S-Benzoylthiamine O-monophosphate, HIV, SARS-CoV, Human immunodeficiency virus, SARS coronavirus, food, supplement, diabetic, complications, antioxidative, Inhibitor, inhibitor, inhibit
References
[1] Allowitz KV, et, al. Therapeutic potential of vitamin B1 derivative benfotiamine from diabetes to COVID-19. Future Med Chem. 2022 Jun;14(11):809-826.
[2] Bozic I, et, al. Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia. PLoS One. 2015 Feb 19;10(2):e0118372.
[3] Wu S, et, al. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett. 2006 Feb 13;394(2):158-62.